Liver receptor homolog-1 (NR5A2) orchestrates hepatic inflammation and TNF-induced cell death

Cell Rep. 2023 Dec 26;42(12):113513. doi: 10.1016/j.celrep.2023.113513. Epub 2023 Nov 30.

Abstract

The nuclear receptor liver receptor homolog-1 (LRH-1) has been shown to promote apoptosis resistance in various tissues and disease contexts; however, its role in liver cell death remains unexplored. Hepatocyte-specific deletion of LRH-1 causes mild steatosis and inflammation but unexpectedly shields female mice from tumor necrosis factor (TNF)-induced hepatocyte apoptosis and associated hepatitis. LRH-1-deficient hepatocytes show markedly attenuated estrogen receptor alpha and elevated nuclear factor κB (NF-κB) activity, while LRH-1 overexpression inhibits NF-κB activity. This inhibition relies on direct physical interaction of LRH-1's ligand-binding domain and the Rel homology domain of NF-κB subunit RelA. Mechanistically, increased transcription of anti-apoptotic NF-κB target genes and the proteasomal degradation of pro-apoptotic BCL-2 interacting mediator of cell death prevent mitochondrial apoptosis and ultimately protect mice from TNF-induced liver damage. Collectively, our study emphasizes LRH-1 as a critical, sex-dependent regulator of cell death and inflammation in the healthy and diseased liver.

Keywords: BIM; CP: Immunology; ERα; LRH-1; NF-κB; TNF; apoptosis; hepatitis; inflammation; liver.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Apoptosis
  • Female
  • Hepatocytes / metabolism
  • Inflammation / pathology
  • Liver / metabolism
  • Mice
  • NF-kappa B* / metabolism
  • Receptors, Cytoplasmic and Nuclear / genetics
  • Receptors, Cytoplasmic and Nuclear / metabolism
  • Tumor Necrosis Factor-alpha* / metabolism

Substances

  • NF-kappa B
  • Tumor Necrosis Factor-alpha
  • Receptors, Cytoplasmic and Nuclear